Information and interesting ideas

Topics posted here will be in the realm of bioanalysis and biomarkers as part of new therapeutic development, with the occasional post of scientific topics that I find interesting.

Tuesday, June 6, 2023

Webinar with 3 presentations on "Agilent’s Theory of Mass Spectrometry: Life Science Edition"

Agilent’s Theory of Mass Spectrometry: Life Science Edition

Thursday, June 29, at 08:00 PDT / 10:00 CDT / 11:00 EDT 

In the words of Albert Einstein, “We cannot solve our problems with the same thinking we used when we created them.” It takes outside-the-box thinking to continue to innovate and push the limits of what is possible. Each day, you and your team work tirelessly to push those boundaries and create a better world, and Agilent is here to help you every step of the way. Instrument intelligence and innovation are of utmost importance, and together we can discover endless possibilities.

Join this webinar series to learn how Agilent's intelligent and innovative mass spectrometry solutions are helping to pave the way to new discoveries in the field.

Session 1 - Accelerating analysis in the biopharma laboratory
08:00 PDT/ 10:00 CDT/ 11:00 EDT

Session 2 - Multi-omic, mass spectrometry-based elucidation of mechanisms of L-asparaginase toxicity in a mouse model of cancer
09:00 PDT/ 11:00 CDT/ 12:00 EDT

Session 3 - Elucidating cellular metabolism with a full suite of next-generation omics tools

10:00 PDT/ 12:00 CDT/ 13:00 EDT

Register here: https://view6.workcast.net/register?cpak=3398767658905354&referrer=SelectScience-Promo-1

No comments:

Post a Comment

FDA and CMS issue statement on LDTs: Americans Deserve Accurate and Reliable Diagnostic Tests, Wherever They Are Made

This joint statement notes the evolution of Laboratory Developed Tests (LDTs) from the initial rule and approach the FDA had for oversite, a...